Linkedin
insta
pinterest
facebook
Design Inspirations
Where We Work
Academia
Atypical Models
Corporate-Affiliated
Independent
Industry/Research
Multidisciplinary
Military/Public Health
Ownership Models
Specialty Services
Growth Strategies
ABB Optical Group
Alcon
Astellas
Avulux
Bausch + Lomb
EssilorLuxottica Eye Care
HELIX
IDOC
L’Amy America
Lumenis
Marco Lombart
National Vision
Optase by Scope Health
Target Optical
Treehouse Eyes
Visioneering Technologies
Visionix
Walmart/Sams Club Community ODs
News & Views
News
Views
Polls
Events
2025 Women’s Leadership Conference
2025 Graduation
Newsmakers
WO Resources
Tips & Tricks
Beauty
Building a Specialty
Health and Wellness
Promoting Yourself
WO Voices Podcasts
Your Money
Jobs
OD Students & Staff
Students
Opticians
Non-Optical Staff
Subscribe to WO!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Women In Optometry
Linkedin
insta
pinterest
facebook
Design Inspirations
Where We Work
Academia
Atypical Models
Corporate-Affiliated
Independent
Industry/Research
Multidisciplinary
Military/Public Health
Ownership Models
Specialty Services
Growth Strategies
ABB Optical Group
Alcon
Astellas
Avulux
Bausch + Lomb
EssilorLuxottica Eye Care
HELIX
IDOC
L’Amy America
Lumenis
Marco Lombart
National Vision
Optase by Scope Health
Target Optical
Treehouse Eyes
Visioneering Technologies
Visionix
Walmart/Sams Club Community ODs
News & Views
News
Views
Polls
Events
2025 Women’s Leadership Conference
2025 Graduation
Newsmakers
WO Resources
Tips & Tricks
Beauty
Building a Specialty
Health and Wellness
Promoting Yourself
WO Voices Podcasts
Your Money
Jobs
OD Students & Staff
Students
Opticians
Non-Optical Staff
Subscribe to WO!
Home
Tags
Slowing vision loss
Tag: slowing vision loss
Astellas
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal...
– IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across...
- Advertisement -
- Advertisment -